Notice of Proposed Sale · 144
Heartflow, Inc.
HTFLNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Heartflow, Inc.
- Issuer CIK
- 0001464521
- SEC file number
- 001-42790
- Phone
- 650-241-1221
- Person for whose account securities are to be sold
- Farquhar John C.M.
- Relationships to issuer
- Officer · Director
- Street
- 135 MAIN STREET, SUITE 1000
- City
- SAN FRANCISCO
- State / country code
- CA
- Postal code
- 94105
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 35,010 | 1,625,104.29 | 86,953,627 | 09/10/2026 | NASDAQ | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 06/25/2024 | Stock Option Exercise | Issuer | 35,010 | N | 06/25/2024 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| John C M Farquhar | Common | 06/10/2026 | 22,562 | 643,017.00 |
| John C M Farquhar | Common | 06/24/2026 | 38,900 | 1,361,500.00 |
| John C M Farquhar | Common | 07/10/2026 | 22,562 | 626,095.50 |
| John C M Farquhar | Common | 08/10/2026 | 22,562 | 638,730.22 |
| John C M Farquhar | Common | 08/14/2026 | 15,560 | 607,773.60 |
| John C M Farquhar | Common | 08/18/2026 | 32,676 | 1,470,420.00 |
| John C M Farquhar | Common | 08/21/2026 | 27,230 | 1,361,500.00 |
Seller — prior-sale row 1, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street
- Street (continued)
- Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Seller — prior-sale row 2, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street
- Street (continued)
- Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Seller — prior-sale row 3, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street
- Street (continued)
- Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Seller — prior-sale row 4, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street, Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Seller — prior-sale row 5, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street, Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Seller — prior-sale row 6, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street
- Street (continued)
- Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Seller — prior-sale row 7, entry 1
- Name
- John C M Farquhar
- Street
- 135 Main Street
- Street (continued)
- Suite 1000
- City
- San Francisco
- State / country code
- CA
- Postal code
- 94105
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 09/10/2026
- Signed
- /s/ Louis Kurnick, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for John C M Farquhar
- Plan adoption dates
- 09/12/2025
Company context
Heartflow’s technology is redefining precision diagnostic testing and management for coronary artery disease (CAD) through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,800 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 625 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 800,000 patients worldwide. 1 Key benefits include: